Tissue engineering is advancing on several fronts, with personalized grafts, bioinks for printing living structures, and off-the-shelf tissue products moving regenerative medicine closer to wider clinical use. The shift matters because it suggests the field is progressing from bespoke laboratory work toward approaches that could be manufactured and distributed more broadly. For professionals, the emphasis on off-the-shelf availability points to the practical challenges of scalability, consistency, and regulatory readiness that will determine clinical adoption.
Regenerative MedicineEthics & SafetyCell Therapy IndustryRead more →
This week’s cell-therapy update includes an AI collaboration aimed at identifying biomarkers that may predict CAR-T response and toxicity, which could support safer and better-targeted treatment. A CRISPR-based system also differentiated human induced pluripotent stem cells toward pancreatic beta cells in four days, while a $550 million acquisition expanded Alcon’s retinal-disease offering. These developments reflect momentum in predictive tools, rapid cell differentiation, and commercial investment across the field.
Regenerative MedicineRegulation & ApprovalRead more →
Dusko Ilic has marked 20 years of the journal Regenerative Medicine by reflecting on the transformative developments that have shaped the field since 2006. His retrospective highlights how sustained chronicling of regenerative medicine and stem cell research has tracked the field’s evolution. For professionals, it offers a concise view of the milestones and shifts that have defined the discipline over two decades.
An animated timeline retraces two decades of regenerative medicine, beginning with the journal’s 2006 launch and moving through early issues, landmark papers, the arrival of RegMedNet, and a special milestone. For professionals, it offers a compact visual retrospective of how the field and its supporting community have evolved. It can serve as a quick orientation or teaching aid for those tracking key developments.